Page last updated: 2024-11-04

sulforaphane and Central Nervous System Origin Vertigo

sulforaphane has been researched along with Central Nervous System Origin Vertigo in 1 studies

sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.

Research Excerpts

ExcerptRelevanceReference
"Sulforaphane (SFP) treatment represses oxidative stress by activating NRF2."5.72Sulforaphane alleviates hypoxic vestibular vertigo (HVV) by increasing NO production via upregulating the expression of NRF2. ( Hu, C; Li, Y; Wang, B; Zhou, L, 2022)
"Sulforaphane (SFP) treatment represses oxidative stress by activating NRF2."1.72Sulforaphane alleviates hypoxic vestibular vertigo (HVV) by increasing NO production via upregulating the expression of NRF2. ( Hu, C; Li, Y; Wang, B; Zhou, L, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhou, L1
Hu, C1
Li, Y1
Wang, B1

Other Studies

1 other study available for sulforaphane and Central Nervous System Origin Vertigo

ArticleYear
Sulforaphane alleviates hypoxic vestibular vertigo (HVV) by increasing NO production via upregulating the expression of NRF2.
    Bioengineered, 2022, Volume: 13, Issue:4

    Topics: Animals; Isothiocyanates; NF-E2-Related Factor 2; Nitric Oxide; Oxidative Stress; Rats; Sulfoxides;

2022